Roosevelt Investment Group LLC reveals Q2 vs. Q3 2022 13F holdings comparison

Roosevelt Investment Group LLC Q2 2022 vs. Q3 2022 13F Holdings Comparison

The Roosevelt Investment Group LLC recently released their Q2 2022 vs. Q3 2022 13F holdings comparison. The comparison shows a summary of the changes in holdings of the fund, analyzing the shares and value percentage changes from Q2 2022 to Q3 2022.

The report summarizes holdings for 50 investment options, including the likes of Apple, Microsoft, and Amazon. The report shows a mix of changes in holdings, with both positive and negative percentage changes across the board.

Chg % - Winners and Losers

The Chg % column in the report highlights the percentage change in holdings from Q2 2022 to Q3 2022, which makes it the best way to understand the direction of trades taken by the fund. Out of the 50 investment options considered, 24 saw a positive percentage change, while 26 saw a negative change.

In terms of the percentage winners, Global Blood Therapeutics, which is indicated with no ticker symbol and Harmony Biosciences Holdings Inc. (HRMY) saw the highest gains at 10000% and 8596%, respectively. The third-highest percentage gainer was Chart Inds Inc. (GTLS) at 13.9%.

On the other hand, the biggest losers were Mondelez Intl Inc. (MDLZ), which saw a decrease of 4090.4%, while Tesla (TSLA) not far behind with an increase of 764.3%. Other major losers include AstraZeneca Plc. (AZN), IBM (IBM), and Celanese Corp Del (CE).

Value Changes

In addition to the number of shares, the total value changed also saw some movements. The total value change is calculated as the change in the value of the holdings from Q2 2022 to Q3 2022. The report shows that 14 out of the 50 investment options saw a positive value change, while 36 showed a decrease in value.

The highest increase in total value was seen in McKesson Corp (MCK), with a massive increase of 73%. The highest decrease in value was in Global Blood Therapeutics and Mondelez Intl Inc., both seeing a decrease of approximately 61% and 13.2% respectively. Other notable value losers include Procter and Gamble Co (PG), Verizon Communications (VZ), and Celanese Corp Del.

Important Changes

The report shows some interesting changes in holdings, which can be significant for investors to follow. One notable change is the inclusion of Harmony Biosciences Holdings Inc. in the fund. This company was previously not held in Q2 2022, but the fund acquired 194,084 shares in Q3 2022. The fund also purchased 34,640 shares of Tesla Inc (TSLA), indicating the positive view of the fund managers towards the EV industry.

The report also indicates that the fund managers reduced their holdings in some companies, such as Constellation Energy Corp (CEG) and International Business Machines (IBM). This could be due to various factors such as portfolio rebalancing, a change in the fund's investment mandate, or re-evaluating the companies' potential.

Conclusion

The Roosevelt Investment Group LLC Q2 2022 vs. Q3 2022 13F Holdings Comparison report shows a mix of positive and negative changes in holdings. The comparison highlights the significant gains and losses in the fund's holdings, which can be useful for investors to monitor their portfolios. Ultimately analyzing the report can give investors valuable insights into the changing perspectives and investment decisions of the fund managers.